Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tvardi Therapeutics (TVRD) Other Gross PP&E Adjustments: 2013-2016

Historic Other Gross PP&E Adjustments for Tvardi Therapeutics (TVRD) over the last 2 years, with Dec 2016 value amounting to $7.9 million.

  • Tvardi Therapeutics' Other Gross PP&E Adjustments rose 10.34% to $7.9 million in Q4 2016 from the same period last year, while for Dec 2016 it was $14.4 million, marking a year-over-year increase of 131.21%. This contributed to the annual value of $7.9 million for FY2016, which is 10.34% up from last year.
  • Tvardi Therapeutics' Other Gross PP&E Adjustments amounted to $7.9 million in Q4 2016, which was up 10.34% from $7.2 million recorded in Q4 2015.
  • In the past 5 years, Tvardi Therapeutics' Other Gross PP&E Adjustments ranged from a high of $7.9 million in Q4 2014 and a low of -$434,000 during Q3 2014.
  • Moreover, its 3-year median value for Other Gross PP&E Adjustments was -$227,000 (2014), whereas its average is $2.4 million.
  • Within the past 5 years, the most significant YoY rise in Tvardi Therapeutics' Other Gross PP&E Adjustments was 19.82% (2015), while the steepest drop was 44.79% (2015).
  • Tvardi Therapeutics' Other Gross PP&E Adjustments (Quarterly) stood at $7.5 million in 2013, then rose by 5.89% to $7.9 million in 2014, then dropped by 9.68% to $7.2 million in 2015, then grew by 10.34% to $7.9 million in 2016.
  • Its Other Gross PP&E Adjustments was $7.9 million in Q4 2016, compared to $7.2 million in Q4 2015 and -$348,000 in Q3 2015.